oral mucosa shredded, swallowing feels like broken glass, taste disappears, weight drops 1–2 kg per week…
The sentence we hear most often is:
“I know I need protein, but I physically can’t eat or swallow anything.”
Virtually every patient on androgen-deprivation therapy (ADT) faces progressive bone loss:
on average 4–7 % per year of treatment,
with fracture risk rising 2- to 5-fold within five years.
A single hip or vertebral fracture can dramatically affect quality of life and prognosis.
For patients on prolonged parenteral nutrition (TPN) — after pancreatic/gastric surgery, short-bowel syndrome, severe Crohn’s disease, or radiation enteritis —
zinc is one of the most easily overlooked yet critically important trace elements.
Only a few milligrams are needed daily, but zinc is involved in over 300 enzymes, wound healing, taste, immunity, and intestinal mucosal repair.
When it is lacking, the body falls into a vicious cycle: wounds won’t close, taste disappears, infections linger, and recovery stalls.
After major pancreatic or gastric surgery (Whipple, distal pancreatectomy, total gastrectomy),
the most common and distressing issues are almost always the same:
feeling full after a few bites, bloating, rapid weight loss, and persistent weakness.
This is not a lack of effort — the digestive system simply cannot absorb enough calories and nutrients in the usual way.
Turning “exhausted all day yet unable to sleep” into steady energy and restful nights
Cancer-related fatigue (CRF) is one of the deepest and most unspoken burdens for the majority of patients.
It is not ordinary tiredness — it is the result of disrupted mitochondrial function, elevated oxidative stress, and persistent low-grade inflammation caused by cancer and its treatments.
Numerous international studies have shown that high-dose intravenous vitamin C (IVC) is one of the safest and most widely recognised supportive options for managing CRF.
Turning “I’m exhausted all day yet can’t sleep at night” into steady daytime energy and restful nights
Cancer-related fatigue (CRF) is not ordinary tiredness — it is the result of cancer and its treatment disrupting the body’s entire energy system.
More than 70 % of patients experience it, yet it is often dismissed with “just rest more”.
Based on years of supporting thousands of patients, we have designed a gentle, practical, home-friendly recovery programme specifically for CRF.
Turning “quiet worry” into a calm, actionable plan
When breast, ovarian, colorectal, pancreatic, thyroid, or multiple cancers have appeared in your family,
the question “Could it happen to me?” often lingers in the background.
The good news: hereditary cancers represent only 5–10 % of all cases — yet this small percentage is the most preventable when identified early.
Turning every visit into a calm confirmation that you are doing well
Thyroid cancer generally has an excellent prognosis, yet the lifelong follow-up journey can quietly weigh on many patients.
With the right rhythm, clear explanations, and genuine support, follow-up can shift from “quiet worry” to “quiet confidence”.
Helping you stay energised and emotionally balanced while finding the right dose
After thyroid cancer surgery, Hashimoto’s thyroiditis, or radioiodine treatment, the most challenging phase is often the “dose-finding” transition period:
feeling hot then cold, palpitations, shaky hands, wanting to sleep all day yet never feeling rested, brain fog, and emotional ups and downs.
These symptoms are almost always temporary, and the right supportive strategies can significantly reduce discomfort.
The answer lies in the unique biological profile of each patient’s tumour — RGCC Onconomics Plus® can read it with precision
The same non-small-cell lung cancer: why do some patients remain stable on osimertinib for over a year while others develop resistance within months?
Triple-negative breast cancer: why do some complete standard chemotherapy with tolerable side effects while others require dose reductions due to severe myelosuppression?
Metastatic colorectal cancer: why do certain individuals achieve long-term disease control when specific natural compounds are added, while others see no benefit?